November 29, 2021

Daily Company News

Better Informed Today

BUSINESS NEWS

Zebra Analytix – Miniaturizes Chromatography Systems And Components Utilizing Patented MEMS Technology

Zebra Analytix will be targeting point-of-need breath and skin analysis for immediate detection of VOCs that identify diseases and cancers.
Listen to this article

Below is our recent interview with John A. Michalek, Chief Executive Officer at Zebra Analytix:

Q: Could you provide our readers with a brief introduction to your company? 

A: Zebra Analytix is focused on miniaturized chromatography systems and components utilizing patented MEMS technology.  These items include Gas Chromatographs, Separation Columns, Pre-Concentrators, and Detectors.  The goal is to provide hand-held analysis capabilities for applications that in the past did not have a solution including air, water, food, and human diseases.

Q: Any highlights on your recent announcement? 

A: After two years with an interim CEO, Zebra has progressed closer to commercialization which instigated the need to hire its first full-time CEO to focus on growth and market acceptance.  We are now moving into the next stage of our company.

Q: Can you give us more insights into your offering?

A: We will be targeting point-of-need breath and skin analysis for immediate detection of VOCs that identify diseases and cancers.

Q: What can we expect from your company in next 6 months? What are your plans?

A: We will be introducing our first mini-GC, the SentinelGCTM, that will sell for under $8,000 and bring the first phase of our technology to fruition.

Q: What is the best thing about your company that people might not know about?

A: We are part of a larger network of companies, the VIC Technology Venture Development ecosystem, that commercializes high impact life science technologies exclusively licensed from top research institutions worldwide.